← Leaderboards
Logan Bedford
Indiana University Indianapolis
$74,121
Attributed
$74,121
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $38.5K · FY2024–25$50K$37.5K$25K$12.5K$0
'24
'25
Funding mix
By agency
NIH$74,121 · 1
By mechanism
F31$74,121 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Paul Richard Territo$22,416,914
- Adrian Lynn Oblak$5,075,046
- Gary E. Landreth$21,167,585
- Suthat Liangpunsakul$8,638,123
- David W. Clapp$30,065,006
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposAmericanExperimental StudyBiochemicalBiologicalBrain CellCell MembraneCellsCellular BiologyComplexCytokineDesignDiglyceridesEnzymesAmyloid Beta-ProteinExtracellularGenesGenetic StudyGenetic TranscriptionGenetic VariantHuman Induced Pluripotent Stem CellsHuman Old Age (65+)HydrolysisAffect
Grant awards (2)
Validating PLCG2 as a target for the treatment of Alzheimer's Disease through cell biology and pharmacological tools$35,608
F31 · FY2025 · AG · contact PI
Validating PLCG2 as a target for the treatment of Alzheimer's Disease through cell biology and pharmacological tools$38,513
F31 · FY2024 · AG · contact PI